The essential role of IGF-I: lessons from the long-term study and treatment of children and adults with Laron syndrome

Intrauterine Growth Retardation and Postnatal Growth Failure Associated with Deletion of the Insulin-Like Growth Factor I Gene

Woods, K. A., Camacho‐Hübner, C., Savage, M. O., & Clark, A. (1996) · New England Journal of Medicine · doi:10.1056/nejm199610313351805 · Cited by 1,083 · see citing works

A mammalian model for Laron syndrome produced by targeted disruption of the mouse growth hormone receptor/binding protein gene (the Laron mouse)

Zhou, Y., Xu, B. C., Maheshwari, H., He, L., Reed, M. A., Lozykowski, M. G., Okada, S., Cataldo, L. R., Coschigamo, K., Wagner, T. E., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.24.13215 · Cited by 802 · see citing works

Characterization of the human growth hormone receptor gene and demonstration of a partial gene deletion in two patients with Laron-type dwarfism.

Godowski, P. J., Leung, D. W., Meacham, L. R., GALGANI, J. P., Hellmiss, R., Keret, R., Rotwein, P. S., Parks, J. S., Laron, Z., & Wood, W. I. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.20.8083 · Cited by 604 · see citing works

Mechanism of the Stimulatory Effect of Growth Hormone on Longitudinal Bone Growth*

Isaksson, O. G. P., Lindahl, A. H., NILSSON, A., & Isgaard, J. (1987) · Endocrine Reviews · doi:10.1210/edrv-8-4-426 · Cited by 579 · see citing works

Short-Term Metabolic Effects of Recombinant Human Insulin-like Growth Factor I in Healthy Adults

Guler, H., Zapf, J., & Froesch, E. R. (1987) · New England Journal of Medicine · doi:10.1056/nejm198707163170303 · Cited by 561 · see citing works

A dual effector theory of growth-hormone action

Green, H., Morikawa, M., & Mxon, T. (1985) · Differentiation · doi:10.1111/j.1432-0436.1985.tb00316.x · Cited by 521 · see citing works

A dominant-negative mutation of the growth hormone receptor causes familial short stature

Ayling, R. M., Ross, R. J. M., Towner, P., et al. (1997) · Nature Genetics · doi:10.1038/ng0597-13 · Cited by 235 · see citing works

Effects of insulin-like growth factor on linear growth, head circumference, and body fat in patients with Laron-type dwarfism

Laron, Z., Anin, S., Aurbach-Klipper, Y., & Klinger, B. (1992) · The Lancet · doi:10.1016/0140-6736(92)91594-x · Cited by 212 · see citing works

Clinical features and endocrine status in patients with growth hormone insensitivity (Laron syndrome).

Savage, M. O., Blum, W. F., Ranke, M., et al. (1993) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.77.6.7505286 · Cited by 203 · see citing works

Administration of Growth Hormone to Patients with Familial Dwarfism with High Plasma Immunoreactive Growth Hormone: Measurement of Sulfation Factor, Metabolic and Linear Growth Responses

Laron, Z., Pertzelan, A., Karp, M., Kowadlo-Silbergeld, A., & Daughaday, W. H. (1971) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-33-2-332 · Cited by 197 · see citing works

An infant with deletion of the distal long arm of chromosome 15 (q26.1→qter) and loss of insulin‐like growth factor 1 receptor gene

Roback, E. W., Barakat, A. J., Dev, V. G., Mbikay, M., Chrétien, M., & Butler, M. G. (1991) · American Journal of Medical Genetics · doi:10.1002/ajmg.1320380117 · Cited by 174 · see citing works

Pituitary dwarfism with high serum levels of growth hormone.

Laron, Z., Pertzelan, A., & Karp, M. (1969) · PubMed · Cited by 162 · see citing works

The Little Women of Loja — Growth Hormone–Receptor Deficiency in an Inbred Population of Southern Ecuador

Rosenbloom, A. L., Guevara‐Aguirre, J., Rosenfeld, R. G., & Fielder, P. J. (1990) · New England Journal of Medicine · doi:10.1056/nejm199011153232002 · Cited by 161 · see citing works

Short Stature Caused by a Mutant Growth Hormone

Takahashi, Y., Kaji, H., Okimura, Y., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199602153340704 · Cited by 160 · see citing works

Preliminary report Dose-responses for the slowing of gastric emptying in a rodent model by glucagon-like peptide (7–36)NH2, amylin, cholecystokinin, and other possible regulators of nutrient uptake

Young, A. A., Gedulin, B. R., & RINK, T. J. (1996) · Metabolism · doi:10.1016/s0026-0495(96)90192-4 · Cited by 150 · see citing works

Phenotype: Genotype Relationships in Growth Hormone Insensitivity Syndrome1

Woods, K. A., Moal, F., Preece, M. A., et al. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.11.4389 · Cited by 150 · see citing works

Effects of the Infusion of Insulin-like Growth Factor I in a Child with Growth Hormone Insensitivity Syndrome (Laron Dwarfism)

Walker, J. L., Ginalska-Malinowska, M., Romer, T. E., Pucilowska, J. B., & Underwood, L. E. (1991) · New England Journal of Medicine · doi:10.1056/nejm199105233242107 · Cited by 139 · see citing works

Growth Hormone (GH) Insensitivity Syndrome with High Serum GH-Binding Protein Levels Caused by a Heterozygous Splice Site Mutation of the GH Receptor Gene Producing a Lack of Intracellular Domain1

Iida, K., Takahashi, Y., Kaji, H., et al. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.2.4601 · Cited by 134 · see citing works

Growth curves for Laron syndrome.

Laron, Z., Lilos, P., & Klinger, B. (1993) · Archives of Disease in Childhood · doi:10.1136/adc.68.6.768 · Cited by 123 · see citing works

Two-Year Treatment of Growth Hormone (GH) Receptor Deficiency with Recombinant Insulin-Like Growth Factor I in 22 Children: Comparison of Two Dosage Levels and to GH-Treated GH Deficiency1

Guevara‐Aguirre, J., Rosenbloom, A. L., Vasconez, O., et al. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.2.3743 · Cited by 121 · see citing works

Puberty in Laron type dwarfism

Laron, Z., Sarel, R., & Pertzelan, A. (1980) · European Journal of Pediatrics · doi:10.1007/bf00442408 · Cited by 118 · see citing works

Three Year IGF-I Treatment of Children with Laron Syndrome

Klinger, B., & Laron, Z. (1995) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem.1995.8.3.149 · Cited by 116 · see citing works

Prolonged treatment with recombinant insulin-like growth factor-I in children with growth hormone insensitivity syndrome--a clinical research center study. GHIS Collaborative Group.

Backeljauw, P. F., & Underwood, L. E. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.9.8784089 · Cited by 110 · see citing works

Growth hormone receptor deficiency in Ecuador: clinical and biochemical phenotype in two populations.

Guevara‐Aguirre, J., Rosenbloom, A. L., Fielder, P. J., et al. (1993) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.76.2.7679400 · Cited by 108 · see citing works

Effect of insulin-like growth factor-I treatment on serum androgens and testicular and penile size in males with Laron syndrome (primary growth hormone resistance)

Laron, Z., & Klinger, B. (1998) · European Journal of Endocrinology · doi:10.1530/eje.0.1380176 · Cited by 107 · see citing works

Clinical features and endocrine status in patients with growth hormone insensitivity (Laron syndrome)

Savage, M. O. (1993) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.77.6.1465 · Cited by 107 · see citing works

Laron-Type Dwarfism (Hereditary Somatomedin Deficiency): A Review

Laron, Z. (1984) · Springer eBooks · doi:10.1007/978-3-642-69070-9_3 · Cited by 106 · see citing works

Factors predicting the response to growth hormone (GH) therapy in prepubertal children with GH deficiency.

Blethen, S. L., Compton, P., Lippe, B. M., et al. (1993) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.76.3.8445013 · Cited by 100 · see citing works

Classification of growth hormone insensitivity syndrome

Laron, Z., Blum, W. F., Chatelain, P., Ranke, M. B., Rosenfeld, R. G., Savage, M. O., & Underwood, L. E. (1993) · The Journal of Pediatrics · doi:10.1016/s0022-3476(06)80120-4 · Cited by 100 · see citing works

EFFECT OF ACUTE ADMINISTRATION OF INSULIN-LIKE GROWTH FACTOR I IN PATIENTS WITH LARON-TYPE DWARFISM

Laron, Z., Erster, B., Klinger, B., & Anin, S. (1988) · The Lancet · doi:10.1016/s0140-6736(88)90236-x · Cited by 98 · see citing works

Growth Hormone (GH) Insensitivity Syndrome with High Serum GH-Binding Protein Levels Caused by a Heterozygous Splice Site Mutation of the GH Receptor Gene Producing a Lack of Intracellular Domain

Iida, K. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.83.2.531 · Cited by 97 · see citing works

Penis and testicular size in patients with growth hormone insufficency.

Laron, Z., & Sarel, R. (1970) · Acta Endocrinologica · doi:10.1530/acta.0.0630625 · Cited by 96 · see citing works

Insulin-Like Growth Factor I Improves Height in Growth Hormone Insensitivity: Two Years’ Results

Ranke, M. B., Savage, M. O., Chatelain, P., et al. (2008) · Hormone Research · doi:10.1159/000184637 · Cited by 95 · see citing works

Development of hyperandrogenism during treatment with insulin‐like growth factor‐I (IGF‐I) in female patients with Laron syndrome

Klinger, V., Anin, Silbergeld, Eshet, & Laron (1998) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1998.00356.x · Cited by 85 · see citing works

Body Fat in Laron Syndrome Patients: Effect of Insulin-Like Growth Factor I Treatment

Laron, Z., & Klinger, B. (2008) · Hormone Research · doi:10.1159/000183762 · Cited by 83 · see citing works

Two-Year Treatment of Growth Hormone (GH) Receptor Deficiency with Recombinant Insulin-Like Growth Factor I in 22 Children: Comparison of Two Dosage Levels and to GH-Treated GH Deficiency

Guevara‐Aguirre, J. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.82.2.629 · Cited by 82 · see citing works

Natural history of the classical form of primary growth hormone (GH) resistance (Laron syndrome).

Laron, Z. (1999) · PubMed · Cited by 78 · see citing works

IGF‐I treatment of adult patients with Laron syndrome: preliminary results

Laron, Z., & Klinger, B. (1994) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1994.tb01829.x · Cited by 75 · see citing works

Phenotype: Genotype Relationships in Growth Hormone Insensitivity Syndrome

Woods, K. A. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.82.11.3529 · Cited by 72 · see citing works

Chemical Synthesis, Cloning, and Expression of Genes for Human Somatomedin C (Insulin‐like Growth Factor I) and 59Val‐Somatomedin C

Niwa, M., Satô, S., Saito, Y., et al. (1986) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1986.tb26482.x · Cited by 66 · see citing works

Nine Novel Growth Hormone Receptor Gene Mutations in Patients with Laron Syndrome1

Sobrier, M., Moal, F., Duquesnoy, P., et al. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.2.3725 · Cited by 61 · see citing works

Intronic Mutation in the Growth Hormone (GH) Receptor Gene from a Girl with Laron Syndrome and Extremely High Serum GH Binding Protein: Extended Phenotypic Study in a Very Large Pedigree

Silbergeld, A., Moal, F., Klinger, B., et al. (1997) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem.1997.10.3.265 · Cited by 61 · see citing works

Is the Laron Mouse an Accurate Model of Laron Syndrome?

Kopchick, J. J., & Laron, Z. (1999) · Molecular Genetics and Metabolism · doi:10.1006/mgme.1999.2890 · Cited by 60 · see citing works

Long-term treatment of Laron type dwarfs with insulin-like growth factor-1 increases serum insulin-like growth factor-binding protein-3 in the absence of growth hormone activity

Kanety, H., Karasik, A., Klinger, B., Silbergeld, A., & Laron, Z. (1993) · European Journal of Endocrinology · doi:10.1530/acta.0.1280144 · Cited by 59 · see citing works

Prismatic cases: Laron syndrome (primary growth hormone resistance) from patient to laboratory to patient.

Laron, Z. (1995) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.80.5.7744997 · Cited by 58 · see citing works

Somatomedin-1 (Recombinant Insulin-Like Growth Factor-1)

Laron, Z. (1999) · BioDrugs · doi:10.2165/00063030-199911010-00006 · Cited by 49 · see citing works

Nine Novel Growth Hormone Receptor Gene Mutations in Patients with Laron Syndrome

Sobrier, M. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.82.2.435 · Cited by 48 · see citing works

Pseudopituitary dwarfism due to resistance to somatomedin: A new syndrome

Bierich, J. R., Moeller, H. C., Ranke, M. B., et al. (1984) · European Journal of Pediatrics · doi:10.1007/bf00442446 · Cited by 46 · see citing works

A Novel Mutation Affecting the Interdomain Link Region of the Growth Hormone Receptor in a Vietnamese Girl, and Response to Long-Term Treatment with Recombinant Human Insulin-Like Growth Factor-I and Luteinizing Hormone-Releasing Hormone Analogue1

Walker, J. L., Crock, P., Behncken, S. N., et al. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.7.4954 · Cited by 46 · see citing works

Intravenous administration of recombinant IGF-I lowers serum GHRH and TSH

Laron, Z., Klinger, B., Silbergeld, A., Lewin, R., Erster, B., & Gil‐Ad, I. (1990) · European Journal of Endocrinology · doi:10.1530/acta.0.1230378 · Cited by 43 · see citing works

Factors predicting the response to growth hormone (GH) therapy in prepubertal children with GH deficiency

Blethen, S. (1993) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.76.3.574 · Cited by 43 · see citing works

Prismatic cases: Laron syndrome (primary growth hormone resistance) from patient to laboratory to patient

Laron, Z. (1995) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.80.5.1526 · Cited by 43 · see citing works

Growth hormone increases and insulin-like growth factor-I decreases circulating lipoprotein(a)

Laron, Z., Wang, X. L., Klinger, B., Silbergeld, A., & Wilcken, D. E. L. (1997) · European Journal of Endocrinology · doi:10.1530/eje.0.1360377 · Cited by 42 · see citing works

Skull Changes in Pituitary Dwarfism and the Syndrome of Familial Dwarfism with High Plasma Immunoreactive Growth Hormone[nl]- A Roentgenologic Study -

Scharf, A., & Laron, Z. (1972) · Hormone and Metabolic Research · doi:10.1055/s-0028-1094075 · Cited by 40 · see citing works

Molecular basis of inherited growth hormone resistance in childhood

Amselem, S., Sobrier, M., Moal, F., et al. (1996) · Baillière s Clinical Endocrinology and Metabolism · doi:10.1016/s0950-351x(96)80485-x · Cited by 38 · see citing works

Laron Syndrome

Laron, Z. (1993) · The Endocrinologist · doi:10.1097/00019616-199301000-00005 · Cited by 36 · see citing works

Echocardiographic dimensions and function in adults with primary growth hormone resistance (Laron Syndrome)

Feinberg, M. S., Scheinowitz, M., & Laron, Z. (2000) · The American Journal of Cardiology · doi:10.1016/s0002-9149(99)00642-6 · Cited by 36 · see citing works

Muscle Force and Endurance in Untreated and Human Growth Hormone or Insulin-Like Growth Factor-l-Treated Patients with Growth Hormone Deficiency or Laron Syndrome

Brat, O., Ziv, I., Klinger, B., et al. (2008) · Hormone Research · doi:10.1159/000185429 · Cited by 34 · see citing works

A Novel Mutation Affecting the Interdomain Link Region of the Growth Hormone Receptor in a Vietnamese Girl, and Response to Long-Term Treatment with Recombinant Human Insulin-Like Growth Factor-I and Luteinizing Hormone-Releasing Hormone Analogue

Walker, J. L. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.83.7.2554 · Cited by 33 · see citing works

EFFECT OF HUMAN GROWTH HORMONE THERAPY ON HEAD CIRCUMFERENCE IN CHILDREN WITH HYPOPITUITARISM

Laron, Z., Roitman, A., & Kauli, R. (1979) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1979.tb02094.x · Cited by 30 · see citing works

Renal function in Laron syndrome patients treated by insulin-like growth factor-I

Klinger, B., & Laron, Z. (1994) · Pediatric Nephrology · doi:10.1007/bf00869089 · Cited by 25 · see citing works

Lessons from Laron syndrome (LS) 1966–1992

DeLamater, P. V. (1994) · Trends in Endocrinology and Metabolism · doi:10.1016/1043-2760(94)90020-5 · Cited by 25 · see citing works

Elimination Characteristics of Intravenously Administered rIGF-I in Laron-Type Dwarfs

Klinger, B., Garty, M., & Laron, Z. (2017) · Developmental Pharmacology and Therapeutics · doi:10.1159/000457646 · Cited by 22 · see citing works

Insulin‐like growth factor‐I raises serum procollagen levels in children and adults with Laron syndrome

Klinger, B., Jensen, L. T., Silbergeld, A., et al. (1996) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1996.7990809.x · Cited by 20 · see citing works

Adjustment and rehabilitation problems of children and adolescents with growth retardation. I. Familial dwarfism with high plasma immunoreactive human growth hormone.

Shurka, E. Z., & Laron, Z. (1975) · PubMed · Cited by 20 · see citing works

Differential effect of insulin-like growth factor-I and growth hormone on hypothalamic regulation of growth hormone secretion in the rat

Ad, I. G., Weizman, A., Silbergeld, A., et al. (1996) · Journal of Endocrinological Investigation · doi:10.1007/bf03349014 · Cited by 19 · see citing works

Insulin Resistance in Laron Syndrome (Primary Insulin-like Growth Factor-I (IGF-I) Deficiency) and Effect of IGF-I Replacement Therapy

Laron, Z., Avitzur, Y., & Klinger, B. (1997) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem.1997.10.s1.105 · Cited by 18 · see citing works

Neonatal primary hyperparathyroidism masked by vitamin D deficiency

Meeran, K. M., Husain, M., Puccini, M., et al. (1994) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1994.tb02586.x · Cited by 13 · see citing works

Short Stature Caused by a Mutant Growth Hormone

(1996) · New England Journal of Medicine · doi:10.1056/nejm199605023341824 · Cited by 11 · see citing works

Serum Insulin-like Growth Factor-I (IGF-I) Levels During Long-term IGF-I Treatment of Children and Adults with Primary GH Resistance (Laron Syndrome)

Laron, Z., Klinger, B., & Silbergeld, A. (1999) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem.1999.12.2.145 · Cited by 10 · see citing works

Hypoglycemia Due to Hormone Deficiencies

Laron, Z. (1998) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem.1998.11.s1.117 · Cited by 8 · see citing works

Girls with Laron Syndrome Having Positive Growth Hormone Binding Protein (GHBP) are Less Retarded in Height Than Those Lacking GHBP

Laron, Z., Desai, M., & Silbergeld, A. (1997) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem.1997.10.3.305 · Cited by 7 · see citing works

Deletion, But Not Antagonism, of the Mouse Growth Hormone Receptor Results in Severely Decreased Body Weights, Insulin, and Insulin-Like Growth Factor I Levels and Increased Life Span

Coschigano, K. T., Holland, A. N., Riders, M. E., List, E. O., Flyvbjerg, A., & Kopchick, J. J. (2003) · Endocrinology · doi:10.1210/en.2003-0374 · Cited by 510 · see citing works

The GH/IGF1 axis and signaling pathways in the muscle and bone: mechanisms underlying age-related skeletal muscle wasting and osteoporosis

Perrini, S., Laviola, L., Carreira, M. C., Cignarelli, A., Natalicchio, A., & Giorgino, F. (2010) · Journal of Endocrinology · doi:10.1677/joe-09-0431 · Cited by 317 · see citing works

Hepatokines and metabolism: Deciphering communication from the liver

Jensen-Cody, S. O., & Potthoff, M. J. (2021) · Molecular Metabolism · doi:10.1016/j.molmet.2020.101138 · Cited by 252 · see citing works

The Consequences of Altered Somatotropic System on Reproduction1

Chandrashekar, V., Zaczek, D., & Bartke, A. (2004) · Biology of Reproduction · doi:10.1095/biolreprod.103.027060 · Cited by 175 · see citing works

Contribution of Liver Fat to Weight Loss–Induced Changes in Serum Hepatokines: A Randomized Controlled Trial

Telgenkamp, I., Kusters, Y. H. A. M., Schalkwijk, C. G., Houben, A. J. H. M., Kooi, M. E., Lindeboom, L., Bons, J. A. P., Schaper, N. C., Joris, P. J., Plat, J., et al. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-02378 · Cited by 18 · see citing works

HYPERANDROGENISM AS A CAUSE OF EARLY POLYCYSTIC OVARY SYNDROME (PCOS) IN GIRLS WITH CENTRAL PRECOCIOUS PUBERTY (CPP)

Lazar, L., Kauli, R., Bruchis, S., et al. (1993) · Pediatric Research · doi:10.1203/00006450-199305001-00065 · Cited by 1 · see citing works

Pre- and postpuberal findings in premature adrenarche.

DiMartino-Nardi, J. (2000) · PubMed · Cited by 29 · see citing works

Insulin Resistance in Prepubertal African–American and Hispanic Girls with Premature Adrenarche: A Risk Factor for Polycystic Ovary Syndrome

DiMartino-Nardi, J. (1998) · Trends in Endocrinology and Metabolism · doi:10.1016/s1043-2760(98)00023-x · Cited by 8 · see citing works

SA53RISK COMMUNICATION IN PSYCHIATRIC GENETIC COUNSELLING: HOW OFTEN DO PATIENTS WANT TO DISCUSS SPECIFIC CHANCES FOR ILLNESS, HOW ARE THESE CHANCES PERCEIVED, AND HOW DO THEY IMPACT PATIENT OUTCOMES?

Borle, K. J., Morris, E. M., Inglis, A. J., et al. (2019) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2018.08.275

History of Polycystic Ovary Syndrome, Premature Adrenarche, and Hyperandrogenism in Pediatric Endocrinology

Witchel, S. F., Azziz, R., & Oberfield, S. E. (2022) · Hormone Research in Paediatrics · doi:10.1159/000526722 · Cited by 26 · see citing works